Aditxt, Inc. Interest Income, Other
Aditxt, Inc. (ADTX) reported Interest Income, Other of $378 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2024-08-19
- Aditxt, Inc. interest income, other for the quarter ending 2024-06-30 was $378.00, a 10.20% increase year-over-year.
- Aditxt, Inc. interest income, other for the quarter ending 2024-03-31 was $377.00, a 95.85% decline year-over-year.
- Aditxt, Inc. interest income, other for the quarter ending 2023-12-31 was $382.00, a 98.60% decline year-over-year.
- Aditxt, Inc. interest income, other for the quarter ending 2023-09-30 was $367.00, a 96.36% decline year-over-year.
- Aditxt, Inc. interest income, other for fiscal 2023 was $10.17K, a 82.27% decline from fiscal 2022.
- Aditxt, Inc. interest income, other for fiscal 2022 was $57.35K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2024-06-30 | $378.00 10-Q · filed 2024-08-19 | $755.00 10-Q · filed 2024-08-19 | $1.14K derived: sum of 3 quarters · filed 2024-08-19 | $1.50K derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | $377.00 10-Q · filed 2024-05-20 | $759.00 derived: sum of 2 quarters · filed 2024-05-20 | $1.13K derived: sum of 3 quarters · filed 2024-05-20 | $1.47K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-12-31 | $382.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $749.00 derived: sum of 2 quarters · filed 2024-04-16 | $1.09K derived: sum of 3 quarters · filed 2024-08-19 | $10.17K 10-K · filed 2024-04-16 |
| 2023-09-30 | $367.00 10-Q · filed 2023-11-14 | $710.00 derived: sum of 2 quarters · filed 2024-08-19 | $9.78K 10-Q · filed 2023-11-14 | $37.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-06-30 | $343.00 10-Q · filed 2024-08-19 | $9.42K 10-Q · filed 2024-08-19 | $36.63K derived: sum of 3 quarters · filed 2024-08-19 | $46.72K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $9.07K 10-Q · filed 2024-05-20 | $36.29K derived: sum of 2 quarters · filed 2024-05-20 | $46.38K derived: sum of 3 quarters · filed 2024-05-20 | $52.38K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $27.22K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $37.30K derived: sum of 2 quarters · filed 2024-04-16 | $43.31K derived: sum of 3 quarters · filed 2024-04-16 | $57.35K 10-K · filed 2024-04-16 |
| 2022-09-30 | $10.08K 10-Q · filed 2023-11-14 | $16.09K derived: sum of 2 quarters · filed 2023-11-14 | $30.13K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $6.01K 10-Q · filed 2023-08-14 | $20.05K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |